Advertisement

Topics

Former Alexion CEO Hallal makes comeback at cell therapy holding firm ElevateBio

08:23 EDT 14 May 2019 | pharmaphorum

Massachusetts holding company ElevateBio has launched with $150m in initial funding from a range of investors on a mission to build a portfolio of cell and gene therapy companies. The biotech is headed by former Alexion CEO David Hallal, with supp...

Original Article: Former Alexion CEO Hallal makes comeback at cell therapy holding firm ElevateBio

NEXT ARTICLE

More From BioPortfolio on "Former Alexion CEO Hallal makes comeback at cell therapy holding firm ElevateBio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...